clinical trial · NCT06777368
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Medtronic Cardiovascular·—·recruiting·n = 225
Aortic StenosisMedtronic TAVEdwards TAV
brief summary
The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
started
Feb 6, 2025
primary completion
Mar 1, 2029
completion
Jul 1, 2033
last updated
Feb 12, 2026
detailed description
Primary Objectives:
* To determine the acute and long-term outcomes of redo TAVR for the treatment of BVF affecting TAVs * To determine the factors which are associated with the acute and long-term outcomes of redo TAVR
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol